{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T13:10:07Z","timestamp":1728133807482},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,5]]},"DOI":"10.7759\/cureus.70880","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T12:29:10Z","timestamp":1728131350000},"source":"Crossref","is-referenced-by-count":0,"title":["Integrative Management of Bone Deformities in Osteogenesis Imperfecta: A Case Report on Zoledronic Acid and Corrective Osteotomy"],"prefix":"10.7759","author":[{"given":"SreeHarsha","family":"Damam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revat J","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4055\/cios20060","article-title":"Management of osteogenesis imperfecta: a multidisciplinary comprehensive approach","volume":"12","author":"Cho TJ","year":"2020","unstructured":"Cho TJ, Ko JM, Kim H, Shin HI, Yoo WJ, Shin CH. Management of osteogenesis imperfecta: a multidisciplinary comprehensive approach. Clin Orthop Surg. 2020, 12:417-29. 10.4055\/cios20060","journal-title":"Clin Orthop Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0299","article-title":"Management of endocrine disease: osteogenesis imperfecta: an update on clinical features and therapies","volume":"183","author":"Marom R","year":"2020","unstructured":"Marom R, Rabenhorst BM, Morello R. Management of endocrine disease: osteogenesis imperfecta: an update on clinical features and therapies. Eur J Endocrinol. 2020, 183:R95-106. 10.1530\/EJE-20-0299","journal-title":"Eur J Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101493","article-title":"Osteogenesis imperfecta: current and prospective therapies","volume":"11","author":"Botor M","year":"2021","unstructured":"Botor M, Fus-Kujawa A, Uroczynska M, Stepien KL, Galicka A, Gawron K, Sieron AL. Osteogenesis imperfecta: current and prospective therapies. Biomolecules. 2021, 11:1493. 10.3390\/biom11101493","journal-title":"Biomolecules"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57050464","article-title":"Current overview of osteogenesis imperfecta","volume":"57","author":"Deguchi M","year":"2021","unstructured":"Deguchi M, Tsuji S, Katsura D, Kasahara K, Kimura F, Murakami T. Current overview of osteogenesis imperfecta. Medicina (Kaunas). 2021, 57:464. 10.3390\/medicina57050464","journal-title":"Medicina (Kaunas)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000813","article-title":"Osteogenesis imperfecta: advancements in genetics and treatment","volume":"31","author":"Rossi V","year":"2019","unstructured":"Rossi V, Lee B, Marom R. Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr. 2019, 31:708-15. 10.1097\/MOP.0000000000000813","journal-title":"Curr Opin Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164A","author":"Van Dijk FS","year":"2014","unstructured":"Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014, 164A:1470-81. 10.1002\/ajmg.a.36545","journal-title":"Am J Med Genet A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e3282f35f03","article-title":"Surgical treatment of osteogenesis imperfecta: current concepts","volume":"20","author":"Esposito P","year":"2008","unstructured":"Esposito P, Plotkin H. Surgical treatment of osteogenesis imperfecta: current concepts. Curr Opin Pediatr. 2008, 20:52-7. 10.1097\/MOP.0b013e3282f35f03","journal-title":"Curr Opin Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2018.03.010","article-title":"Osteogenesis imperfecta and therapeutics","volume":"71-2","author":"Morello R","year":"2018","unstructured":"Morello R. Osteogenesis imperfecta and therapeutics. Matrix Biol. 2018, 71-2:294-312. 10.1016\/j.matbio.2018.03.010","journal-title":"Matrix Biol"},{"key":"ref9","article-title":"Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review","author":"Castillo H","year":"2009","unstructured":"Castillo H, Samson-Fang L. Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review. Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews. Centre for Reviews and Dissemination, York, UK; 2009."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181bdce0a","article-title":"Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial","volume":"114","author":"McClung M","year":"2009","unstructured":"McClung M, Miller P, Recknor C, Mesenbrink P, Bucci-Rechtweg C, Benhamou CL. Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial. Obstet Gynecol. 2009, 114:999-1007. 10.1097\/AOG.0b013e3181bdce0a","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3723-3","article-title":"Osteogenesis imperfecta in children and adolescents\u2014new developments in diagnosis and treatment","volume":"27","author":"Trejo P","year":"2016","unstructured":"Trejo P, Rauch F. Osteogenesis imperfecta in children and adolescents\u2014new developments in diagnosis and treatment. Osteoporos Int. 2016, 27:3427-37. 10.1007\/s00198-016-3723-3","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.05.005","article-title":"Mechanotherapy: revisiting physical therapy and recruiting mechanobiology for a new era in medicine","volume":"19","author":"Huang C","year":"2013","unstructured":"Huang C, Holfeld J, Schaden W, Orgill D, Ogawa R. Mechanotherapy: revisiting physical therapy and recruiting mechanobiology for a new era in medicine. Trends Mol Med. 2013, 19:555-64. 10.1016\/j.molmed.2013.05.005","journal-title":"Trends Mol Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300154-integrative-management-of-bone-deformities-in-osteogenesis-imperfecta-a-case-report-on-zoledronic-acid-and-corrective-osteotomy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T12:29:12Z","timestamp":1728131352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300154-integrative-management-of-bone-deformities-in-osteogenesis-imperfecta-a-case-report-on-zoledronic-acid-and-corrective-osteotomy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,5]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.70880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,5]]}}}